VIM and breast cancer: In this study, we demonstrated that FRMD3, which is significantly downregulated in breast cancer, binds with vimentin through its ubiquitin-like domain, leading to the ubiquitination-mediated degradation of vimentin via recruiting ubiquitin ligase UBE3A in breast cancer cells.